Clinical evaluation of rosoxacin for the treatment of chancroid.
One hundred seven men with Haemophilus ducreyi-positive chancroid were assigned to receive 300 mg of rosoxacin as a single dose or 150 mg twice daily for 3 days. Ulcers and buboes were followed clinically and bacteriologically for 1 month. Of 40 evaluable males on the 3-day regimen, 38 (95%) were cu...
Na minha lista:
| Udgivet i: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology (ASM)
1986
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176431/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3489439/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.30.1.39 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
